SHAKER HEIGHTS, Ohio,
Jan. 12, 2022 /PRNewswire/
-- Gardiner Healthcare Acquisitions Corp. (the
"Company") (NASDAQ:GDNRU) announced today that, commencing
January 13, 2022, holders of the
units sold in the Company's initial public offering may elect to
separately trade the Company's shares of common stock and warrants
included in the units. The shares of common stock and the warrants
that are separated will trade on the NASDAQ Global Market
("NASDAQ") under the ticker symbols "GDNR" and "GDNRW,"
respectively. Those units not separated will continue to trade on
NASDAQ under the symbol "GDNRU." Holders of the units will need to
have their brokers contact Continental Stock Transfer & Trust
Company, the Company's transfer agent, to separate the units into
shares of common stock and warrants.
Gardiner Healthcare Acq. Announces the Separate Trading of its
shares of Common Stock and Warrants
The units were initially offered by the Company in an
underwritten offering. Chardan acted as sole book-running manager
for the offering. B. Riley Securities, Inc. acted as qualified
independent underwriter in the offering.
The registration statement relating to the securities of the
Company was declared effective by the U.S. Securities and Exchange
Commission (the "SEC") on December 21,
2021. This press release shall not constitute an offer to
sell or a solicitation of an offer to buy, nor shall there be any
sale of these securities in any state or jurisdiction in which such
offer, solicitation or sale would be unlawful prior to registration
or qualification under the securities laws of any such state or
jurisdiction.
About Gardiner Healthcare Acquisitions Corp.
The Company is a blank check company formed for the purpose of
effecting a merger, capital stock exchange, asset acquisition,
stock purchase, reorganization or similar business combination with
one or more businesses.
The Company is led by Chairman and Chief Executive Officer
Marc F. Pelletier, PhD; Chief
Financial Officer David P. Jenkins;
and Executive Vice President, Director, and Chief Development
Officer Paul R. McGuirk, PhD.
Cautionary Note Concerning Forward-Looking
Statements
This press release contains statements that constitute
"forward-looking statements," including with respect to the
search for an initial business combination. No assurance can be
given that an initial business combination will be completed.
Forward-looking statements are subject to numerous conditions, many
of which are beyond the control of the Company, including those set
forth in the Risk Factors section of the Company's registration
statement and final prospectus for the initial public offering
filed with the SEC. Copies are available on the SEC's website,
www.sec.gov. The Company undertakes no obligation to update these
statements for revisions or changes after the date of this release,
except as required by law.
Contact
Marc F. Pelletier, PhD
Gardiner Healthcare Acquisitions Corp.
Email: ir@gardinerhealthcare.com
View original
content:https://www.prnewswire.com/news-releases/gardiner-healthcare-acquisitions-corp-announces-the-separate-trading-of-its-shares-of-common-stock-and-warrants-commencing-january-13-2022-301458878.html
SOURCE Gardiner Healthcare Acquisitions Corp.